TY - JOUR
T1 - IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2
AU - Al-Kofahi, M.
AU - Becker, F.
AU - Gavins, F. N.E.
AU - Woolard, M. D.
AU - Tsunoda, I.
AU - Wang, Y.
AU - Ostanin, D.
AU - Zawieja, D. C.
AU - Muthuchamy, M.
AU - Von Der Weid, P. Y.
AU - Alexander, J. S.
N1 - Publisher Copyright:
© 2015 The British Pharmacological Society.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Background and Purpose The lymphatic system maintains tissue homeostasis by unidirectional lymph flow, maintained by tonic and phasic contractions within subunits, 'lymphangions'. Here we have studied the effects of the inflammatory cytokine IL-1β on tonic contraction of rat mesenteric lymphatic muscle cells (RMLMC). Experimental Approach We measured IL-1β in colon-conditioned media (CM) from acute (AC-CM, dextran sodium sulfate) and chronic (CC-CM, T-cell transfer) colitis-induced mice and corresponding controls (Con-AC/CC-CM). We examined tonic contractility of RMLMC in response to CM, the cytokines h-IL-1β or h-TNF-α (5, 10, 20ng·mL-1), with or without COX inhibitors [TFAP (10-5M), diclofenac (0.2 × 10-5M)], PGE2 (10-5M)], IL-1-receptor antagonist, Anakinra (5μg·mL-1), or a selective prostanoid EP4 receptor antagonist, GW627368X (10-6 and 10-7M). Key Results Tonic contractility of RMLMC was reduced by AC- and CC-CM compared with corresponding control culture media, Con-AC/CC-CM. IL-1β or TNF-α was not found in Con-AC/CC-CM, but detected in AC- and CC-CM. h-IL-1β concentration-dependently decreased RMLMC contractility, whereas h-TNF-α showed no effect. Anakinra blocked h-IL-1β-induced RMLMC relaxation, and with AC-CM, restored contractility to RMLMC. IL-1β increased COX-2 protein and PGE2 production in RMLMC. PGE2 induced relaxations in RMLMC, comparable to h-IL-1β. Conversely, COX-2 and EP4 receptor inhibition reversed relaxation induced by IL-1β. Conclusions and Implications The IL-1β-induced decrease in RMLMC tonic contraction was COX-2 dependent, and mediated by PGE2. In experimental colitis, IL-1β and tonic lymphatic contractility were causally related, as this cytokine was critical for the relaxation induced by AC-CM and pharmacological blockade of IL-1β restored tonic contraction.
AB - Background and Purpose The lymphatic system maintains tissue homeostasis by unidirectional lymph flow, maintained by tonic and phasic contractions within subunits, 'lymphangions'. Here we have studied the effects of the inflammatory cytokine IL-1β on tonic contraction of rat mesenteric lymphatic muscle cells (RMLMC). Experimental Approach We measured IL-1β in colon-conditioned media (CM) from acute (AC-CM, dextran sodium sulfate) and chronic (CC-CM, T-cell transfer) colitis-induced mice and corresponding controls (Con-AC/CC-CM). We examined tonic contractility of RMLMC in response to CM, the cytokines h-IL-1β or h-TNF-α (5, 10, 20ng·mL-1), with or without COX inhibitors [TFAP (10-5M), diclofenac (0.2 × 10-5M)], PGE2 (10-5M)], IL-1-receptor antagonist, Anakinra (5μg·mL-1), or a selective prostanoid EP4 receptor antagonist, GW627368X (10-6 and 10-7M). Key Results Tonic contractility of RMLMC was reduced by AC- and CC-CM compared with corresponding control culture media, Con-AC/CC-CM. IL-1β or TNF-α was not found in Con-AC/CC-CM, but detected in AC- and CC-CM. h-IL-1β concentration-dependently decreased RMLMC contractility, whereas h-TNF-α showed no effect. Anakinra blocked h-IL-1β-induced RMLMC relaxation, and with AC-CM, restored contractility to RMLMC. IL-1β increased COX-2 protein and PGE2 production in RMLMC. PGE2 induced relaxations in RMLMC, comparable to h-IL-1β. Conversely, COX-2 and EP4 receptor inhibition reversed relaxation induced by IL-1β. Conclusions and Implications The IL-1β-induced decrease in RMLMC tonic contraction was COX-2 dependent, and mediated by PGE2. In experimental colitis, IL-1β and tonic lymphatic contractility were causally related, as this cytokine was critical for the relaxation induced by AC-CM and pharmacological blockade of IL-1β restored tonic contraction.
UR - http://www.scopus.com/inward/record.url?scp=84937517265&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937517265&partnerID=8YFLogxK
U2 - 10.1111/bph.13194
DO - 10.1111/bph.13194
M3 - Article
C2 - 25989136
AN - SCOPUS:84937517265
SN - 0007-1188
VL - 172
SP - 4038
EP - 4051
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 16
ER -